__timestamp | Pharming Group N.V. | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 14182353 | 855506000 |
Thursday, January 1, 2015 | 15503028 | 996170000 |
Friday, January 1, 2016 | 16183585 | 1047690000 |
Sunday, January 1, 2017 | 22382849 | 1324625000 |
Monday, January 1, 2018 | 33038206 | 1416476000 |
Tuesday, January 1, 2019 | 31777040 | 1754540000 |
Wednesday, January 1, 2020 | 41464134 | 1829537000 |
Friday, January 1, 2021 | 67178053 | 3051100000 |
Saturday, January 1, 2022 | 52531000 | 2540300000 |
Sunday, January 1, 2023 | 68914000 | 3162900000 |
Monday, January 1, 2024 | 3630300000 |
Unleashing the power of data
In the ever-evolving world of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Vertex Pharmaceuticals Incorporated and Pharming Group N.V. have demonstrated contrasting trajectories in their R&D investments. Vertex, a leader in the field, has consistently increased its R&D spending, peaking at over $3 billion in 2023, a staggering 270% increase from 2014. This commitment underscores Vertex's dedication to pioneering treatments and maintaining its competitive edge.
Conversely, Pharming Group N.V. has shown a more modest growth in R&D expenditure, with a 385% increase from 2014 to 2023, reaching nearly $69 million. While smaller in scale, Pharming's strategic investments reflect its focus on niche markets and targeted therapies. This comparison highlights the diverse strategies within the industry, where both giants and niche players contribute to the advancement of medical science.
Comparing Innovation Spending: Johnson & Johnson and Pharming Group N.V.
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vertex Pharmaceuticals Incorporated and Novavax, Inc.
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation